Speeding up access to new drugs for CF: Considerations for clinical trial design and delivery

Authors:

Abstract
No abstract available
Funding Information
  • Vertex Pharmaceuticals
  • European Medicines Agency
  • Cystic Fibrosis Foundation

This publication has 30 references indexed in Scilit: